HC Wainwright cuts Tyra Biosciences price target to $30
HC Wainwright & Co. maintained its Buy rating on Tyra Biosciences while cutting its price target to $30.00 a share from $45.00.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.